Loading…
Lobbying Spend
—
Filings
12
Firms Hired
1
Active Period
2015–2017
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Charlotte's Web Medical Access Act of 2015
2016 · fourth_quarter · Firm: SIDLEY AUSTIN LLP
FDA and DEA regulation of cannabidiol; monitor S. 1333 (Therapeutic Hemp Medical Access Act of 2015), HR 1635 (Charlotte's Web Medical Access Act of 2015), S. 683/S. 1538 (Compassionate Access, Research Expansion and Respect States Act) and activity related to medical marijuana research
Client expense: — · Firm income: $10,000
Matched citations: HR 1635
Therapeutic Hemp Medical Access Act of 2015
2016 · fourth_quarter · Firm: SIDLEY AUSTIN LLP
FDA and DEA regulation of cannabidiol; monitor S. 1333 (Therapeutic Hemp Medical Access Act of 2015), HR 1635 (Charlotte's Web Medical Access Act of 2015), S. 683/S. 1538 (Compassionate Access, Research Expansion and Respect States Act) and activity related to medical marijuana research
Client expense: — · Firm income: $10,000
Matched citations: S. 1333
FDA and DEA regulation of cannabidiol; monitor S. 1333 (Therapeutic Hemp Medical Access Act of 2015), HR 1635 (Charlotte's Web Medical Access Act of 2015), S. 683/S. 1538 (Compassionate Access, Research Expansion and Respect States Act) and activity related to medical marijuana research
Client expense: — · Firm income: $10,000
Matched citations: S. 1538
Compassionate Access, Research Expansion, and Respect States Act of 2015
2016 · fourth_quarter · Firm: SIDLEY AUSTIN LLP
FDA and DEA regulation of cannabidiol; monitor S. 1333 (Therapeutic Hemp Medical Access Act of 2015), HR 1635 (Charlotte's Web Medical Access Act of 2015), S. 683/S. 1538 (Compassionate Access, Research Expansion and Respect States Act) and activity related to medical marijuana research
Client expense: — · Firm income: $10,000
Matched citations: S. 683
Charlotte's Web Medical Access Act of 2015
2016 · third_quarter · Firm: SIDLEY AUSTIN LLP
FDA and DEA regulation of cannabidiol; monitor S. 1333 (Therapeutic Hemp Medical Access Act of 2015), HR 1635 (Charlotte's Web Medical Access Act of 2015), S. 683/S. 1538 (Compassionate Access, Research Expansion and Respect States Act) and activity related to medical marijuana research
Client expense: — · Firm income: $20,000
Matched citations: HR 1635
Therapeutic Hemp Medical Access Act of 2015
2016 · third_quarter · Firm: SIDLEY AUSTIN LLP
FDA and DEA regulation of cannabidiol; monitor S. 1333 (Therapeutic Hemp Medical Access Act of 2015), HR 1635 (Charlotte's Web Medical Access Act of 2015), S. 683/S. 1538 (Compassionate Access, Research Expansion and Respect States Act) and activity related to medical marijuana research
Client expense: — · Firm income: $20,000
Matched citations: S. 1333
FDA and DEA regulation of cannabidiol; monitor S. 1333 (Therapeutic Hemp Medical Access Act of 2015), HR 1635 (Charlotte's Web Medical Access Act of 2015), S. 683/S. 1538 (Compassionate Access, Research Expansion and Respect States Act) and activity related to medical marijuana research
Client expense: — · Firm income: $20,000
Matched citations: S. 1538
Compassionate Access, Research Expansion, and Respect States Act of 2015
2016 · third_quarter · Firm: SIDLEY AUSTIN LLP
FDA and DEA regulation of cannabidiol; monitor S. 1333 (Therapeutic Hemp Medical Access Act of 2015), HR 1635 (Charlotte's Web Medical Access Act of 2015), S. 683/S. 1538 (Compassionate Access, Research Expansion and Respect States Act) and activity related to medical marijuana research
Client expense: — · Firm income: $20,000
Matched citations: S. 683
Charlotte's Web Medical Access Act of 2015
2016 · second_quarter · Firm: SIDLEY AUSTIN LLP
FDA and DEA regulation of cannabidiol; monitor S. 1333 (Therapeutic Hemp Medical Access Act of 2015), HR 1635 (Charlotte's Web Medical Access Act of 2015), S. 683/S. 1538 (Compassionate Access, Research Expansion and Respect States Act) and activity related to medical marijuana research
Client expense: — · Firm income: —
Matched citations: HR 1635
Therapeutic Hemp Medical Access Act of 2015
2016 · second_quarter · Firm: SIDLEY AUSTIN LLP
FDA and DEA regulation of cannabidiol; monitor S. 1333 (Therapeutic Hemp Medical Access Act of 2015), HR 1635 (Charlotte's Web Medical Access Act of 2015), S. 683/S. 1538 (Compassionate Access, Research Expansion and Respect States Act) and activity related to medical marijuana research
Client expense: — · Firm income: —
Matched citations: S. 1333
FDA and DEA regulation of cannabidiol; monitor S. 1333 (Therapeutic Hemp Medical Access Act of 2015), HR 1635 (Charlotte's Web Medical Access Act of 2015), S. 683/S. 1538 (Compassionate Access, Research Expansion and Respect States Act) and activity related to medical marijuana research
Client expense: — · Firm income: —
Matched citations: S. 1538
Compassionate Access, Research Expansion, and Respect States Act of 2015
2016 · second_quarter · Firm: SIDLEY AUSTIN LLP
FDA and DEA regulation of cannabidiol; monitor S. 1333 (Therapeutic Hemp Medical Access Act of 2015), HR 1635 (Charlotte's Web Medical Access Act of 2015), S. 683/S. 1538 (Compassionate Access, Research Expansion and Respect States Act) and activity related to medical marijuana research
Client expense: — · Firm income: —
Matched citations: S. 683
Therapeutic Hemp Medical Access Act of 2015
2015 · fourth_quarter · Firm: SIDLEY AUSTIN LLP
FDA and DEA regulation of cannabidiol; support of and technical changes to S. 481 (Improving Regulatory Transparency for New Medical Therapies Act); S. 1333 (Therapeutic Hemp Medical Access Act of 2015)
Client expense: — · Firm income: $20,000
Matched citations: S. 1333
Improving Regulatory Transparency for New Medical Therapies Act
2015 · fourth_quarter · Firm: SIDLEY AUSTIN LLP
FDA and DEA regulation of cannabidiol; support of and technical changes to S. 481 (Improving Regulatory Transparency for New Medical Therapies Act); S. 1333 (Therapeutic Hemp Medical Access Act of 2015)
Client expense: — · Firm income: $20,000
Matched citations: S. 481
Therapeutic Hemp Medical Access Act of 2015
2015 · third_quarter · Firm: SIDLEY AUSTIN LLP
FDA and DEA regulation of cannabidiol; support of and technical changes to S. 481 (Improving Regulatory Transparency for New Medical Therapies Act); S. 1333 (Therapeutic Hemp Medical Access Act of 2015)
Client expense: — · Firm income: $180,000
Matched citations: S. 1333
Improving Regulatory Transparency for New Medical Therapies Act
2015 · third_quarter · Firm: SIDLEY AUSTIN LLP
FDA and DEA regulation of cannabidiol; support of and technical changes to S. 481 (Improving Regulatory Transparency for New Medical Therapies Act); S. 1333 (Therapeutic Hemp Medical Access Act of 2015)
Client expense: — · Firm income: $180,000
Matched citations: S. 481
Therapeutic Hemp Medical Access Act of 2015
2015 · second_quarter · Firm: SIDLEY AUSTIN LLP
FDA and DEA regulation of cannabidiol; support of and technical changes to S. 481 (Improving Regulatory Transparency for New Medical Therapies Act); S. 1333 (Therapeutic Hemp Medical Access Act of 2015)
Client expense: — · Firm income: $20,000
Matched citations: S. 1333
Improving Regulatory Transparency for New Medical Therapies Act
2015 · second_quarter · Firm: SIDLEY AUSTIN LLP
FDA and DEA regulation of cannabidiol; support of and technical changes to S. 481 (Improving Regulatory Transparency for New Medical Therapies Act); S. 1333 (Therapeutic Hemp Medical Access Act of 2015)
Client expense: — · Firm income: $20,000
Matched citations: S. 481
Therapeutic Hemp Medical Access Act of 2015
2015 · second_quarter · Firm: SIDLEY AUSTIN LLP
FDA and DEA regulation of cannabidiol; support of and technical changes to S. 481 (Improving Regulatory Transparency for New Medical Therapies Act); S. 1333 (Therapeutic Hemp Medical Access Act of 2015)
Client expense: — · Firm income: —
Matched citations: S. 1333
Improving Regulatory Transparency for New Medical Therapies Act
2015 · second_quarter · Firm: SIDLEY AUSTIN LLP
FDA and DEA regulation of cannabidiol; support of and technical changes to S. 481 (Improving Regulatory Transparency for New Medical Therapies Act); S. 1333 (Therapeutic Hemp Medical Access Act of 2015)
Client expense: — · Firm income: —
Matched citations: S. 481
Source: Senate LDA